These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4537969)

  • 41. [Bruden in the therapy of rheumatic diseases].
    Vachtenheim J
    Vnitr Lek; 1972 Jan; 18(1):49-53. PubMed ID: 4536855
    [No Abstract]   [Full Text] [Related]  

  • 42. Ibuprofen: a review of its pharmacological properties and therapeutic efficacy in rheumatic disorders.
    Davies EF; Avery GS
    Drugs; 1971; 2(5):416-46. PubMed ID: 4948543
    [No Abstract]   [Full Text] [Related]  

  • 43. [Observations on the therapeutic efficacy and tolerability of a new drug with anti-inflammatory and analgesic action in patients with arthropathies of various types].
    Coltorti M
    Minerva Med; 1967 Apr; 58(32):1424-9. PubMed ID: 6029505
    [No Abstract]   [Full Text] [Related]  

  • 44. [Open clinical study of the use of 3-(4-biphenylcarbonyl) propionic acid in rheumatoid arthritis and arthrosis].
    Accardo S; Barisone G; Samantà E; Buffrini L; Zecchino MM
    Clin Ter; 1981 Jan; 96(1):55-65. PubMed ID: 7237949
    [No Abstract]   [Full Text] [Related]  

  • 45. Naproxen. Proceedings from an International Medical Symposium presented by Syntex Corporation 7-8 May 1973, Geneva, Switzerland.
    Scand J Rheumatol Suppl; 1973; 2():1-181. PubMed ID: 4544036
    [No Abstract]   [Full Text] [Related]  

  • 46. [What can we expect from an anti-inflammatory agent after 3 years of experimentation and rheumatologic practice?].
    Weissenbach R
    Therapeutique; 1972 Dec; 48(10):685-8. PubMed ID: 4540974
    [No Abstract]   [Full Text] [Related]  

  • 47. The long-term benefits of ibuprofen in rheumatological practice. Interim report.
    Goldberg AA; Hall JE; Buckler JW; Dodsworth PG
    Practitioner; 1971 Sep; 207(239):343-8. PubMed ID: 5095841
    [No Abstract]   [Full Text] [Related]  

  • 48. [Flufenamic acid in rheumatology].
    Cabanel G; Phélip X; Verdier JM
    J Med Lyon; 1970 Oct; 51(195):1771-2 passim. PubMed ID: 5317350
    [No Abstract]   [Full Text] [Related]  

  • 49. Fenbufen--a new nonsteroidal anti-inflammatory agent: comparison with phenylbutazone in rheumatoid arthritis.
    De Salcedo I
    Curr Ther Res Clin Exp; 1975 Aug; 18(2):295-302. PubMed ID: 809242
    [No Abstract]   [Full Text] [Related]  

  • 50. [Treatment of degenerative and inflammatory joint diseases with or without a new synthetic substance (parsalmide). Controlled clinical trial].
    Napoli A; Alderuccio B; Nannetti A
    Clin Ter; 1977 Dec; 83(5):541-7. PubMed ID: 343972
    [No Abstract]   [Full Text] [Related]  

  • 51. [Clinical studies on the effect of a new non-steroid drug in osteoarticular diseases].
    Greco B
    Minerva Med; 1973 Jun; 64(47):2511-2. PubMed ID: 4579842
    [No Abstract]   [Full Text] [Related]  

  • 52. [Report from Drug Evaluation Committee: Clinical evaluation of pranoprofen in rheumatoid arthritis (author's transl)].
    Sichikawa K; Igarashi M; Ogawa N
    Ryumachi; 1979 Aug; 19(4):379-95. PubMed ID: 395672
    [No Abstract]   [Full Text] [Related]  

  • 53. [Evaluation of 19583RP (ketoprofen) in the treatment of chronic rheumatoid arthritis].
    Shiokawa Y; Abe T; Onoda T
    Ryumachi; 1974 Oct; 14(3):279-86. PubMed ID: 4615379
    [No Abstract]   [Full Text] [Related]  

  • 54. [Clinical experimentation of calcium bucloxate (804 CB) in rheumatology].
    Louyot P; Tamisier JN; Pourel J
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1428-31. PubMed ID: 4614820
    [No Abstract]   [Full Text] [Related]  

  • 55. [Clinical trial of a new phenylalcanoic acid derivative].
    Chériè Lignière G; Colombo B; Carrabba M
    Minerva Med; 1973 May; 64(34):1815-20. PubMed ID: 4578239
    [No Abstract]   [Full Text] [Related]  

  • 56. [A double-blind multi-center clinical trial of benoxaprofen against indomethacin in rheumatoid arthritis (author's transl)].
    Shichikawa K; Aritomi H; Ogawa N
    Ryumachi; 1982 Feb; 22(1):88-102. PubMed ID: 7046091
    [No Abstract]   [Full Text] [Related]  

  • 57. [Particular aspect of the drug therapy of rheumatoid arthritis: fenbufen and morning stiffness].
    Tuzi T; Schiavetti L
    Clin Ter; 1978 Jan; 84(1):65-9. PubMed ID: 630813
    [No Abstract]   [Full Text] [Related]  

  • 58. [Appraisal of long-term therapy of inflammatory rheumatic diseases with tauredon, indomethacin, brufen and volon].
    Banciu M; Seceleanu A; Tiroch L
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979; 31(6):541-8. PubMed ID: 44757
    [No Abstract]   [Full Text] [Related]  

  • 59. [Open clinical study with the antirheumatic agent 2-4 isobutyl-phenyl-propionic acid].
    Ruiz Perez LC; Goiz Duran J; Gallegos Navarro CF
    Prensa Med Mex; 1971 Oct; 36(9):448-50. PubMed ID: 4943104
    [No Abstract]   [Full Text] [Related]  

  • 60. [Bumadizone-calcium in rheumatic diseases. Clinical study].
    Bröll H; Tausch G; Sochor H; Eberl R
    MMW Munch Med Wochenschr; 1974 Feb; 116(15):339-40. PubMed ID: 4209902
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.